S100A4 and amyotrophic lateral sclerosis: In addition, these data may propose S100A4 as a possible candidate biomarker of the disease, even though further investigations will be needed to evaluate its expression in fibroblasts from patients carrying other ALS-related mutations as well as in the sporadic cases.